文献速递胃肠外科围术期管理与 ERAS

头孢曲松联合甲硝唑优于单用头孢西丁预防儿童非复杂性阑尾炎手术部位感染

Ceftriaxone Combined With Metronidazole is Superior to Cefoxitin Alone in the Management of Uncomplicated Appendicitis in Children: Results from a Multicenter Collaborative Comparative Effectiveness Study.
PubMed 文献 · Ann Surg · 2021-01-01

多变量模型显示,联合方案与SSI风险降低90%相关(0.2% vs 2.7%;OR 0.10,95%CI 0.02-0.60;P=0.01)。

要点

  • 儿童非复杂性阑尾炎中,头孢曲松联合甲硝唑较单用头孢西丁显著降低SSI风险。
  • 联合方案组SSI发生率为0.2%,单药组为2.7%(OR 0.10,P=0.01)。
  • 窄谱抗生素选择可能影响SSI预防效果,需关注具体方案。

核心结论

  • 在儿童非复杂性阑尾炎中,头孢曲松联合甲硝唑预防SSI优于单用头孢西丁。

研究设计与样本

  • 多中心回顾性队列研究,使用2013年1月至2015年6月儿科国家手术质量改进项目阑尾切除术协作试点数据库与儿科健康信息系统抗生素使用数据合并。

主要发现

  • 总体SSI发生率为1.3%。
  • 56.0%患者接受头孢曲松联合甲硝唑(医院范围0%-100%),44.0%接受头孢西丁(范围0%-100%)。
  • 多变量模型中,头孢曲松联合甲硝唑组SSI发生率为0.2%,头孢西丁组为2.7%,OR 0.10(95%CI 0.02-0.60),P=0.01。

临床怎么用

  • 对于儿童非复杂性阑尾炎,可优先考虑头孢曲松联合甲硝唑作为预防SSI的窄谱抗生素方案。

局限性

  • 回顾性研究设计可能存在选择偏倚和混杂。
  • 抗生素使用数据来自数据库,可能存在记录不准确。
  • 结论需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare rates of surgical site infection between the 2 most commonly utilized narrow-spectrum antibiotic regimens in children with uncomplicated appendicitis (ceftriaxone with metronidazole and cefoxitin alone). SUMMARY OF BACKGROUND DATA: Narrow-spectrum antibiotics have been found to be equivalent to extended-spectrum (antipseudomonal) agents in preventing surgical site infection (SSI) in children with uncomplicated appendicitis. The comparative effectiveness of different narrow-spectrum agents has not been reported. METHODS: This was a multicenter retrospective cohort study using clinical data from the Pediatric National Surgical Quality Improvement Program Appendectomy Collaborative Pilot database merged with antibiotic utilization data from the Pediatric Health Information System database from January 2013 to June 2015. Multivariable logistic regression was used to compare outcomes between antibiotic treatment groups after adjusting for patient characteristics, surrogate measures of disease severity, and clustering of outcomes within hospitals. RESULTS: Eight hundred forty-six patients from 14 hospitals were included in the final study cohort with an overall SSI rate of 1.3%. A total of 56.0% of patients received ceftriaxone with metronidazole (hospital range: 0%-100%) and 44.0% received cefoxitin (range: 0%-100%). In the multivariable model, ceftriaxone with metronidazole was associated with a 90% reduction in the odds of a SSI compared to cefoxitin [0.2% vs 2.7%; odds ratio: 0.10 (95% confidence interval 0.02-0.60); P = 0.01]. CONCLUSIONS: Ceftriaxone combined with metronidazole is superior to cefoxitin alone in preventing SSIs in children with uncomplicated appendicitis.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kashtan MA, Graham DA, Melvin P, et al. Ceftriaxone Combined With Metronidazole is Superior to Cefoxitin Alone in the Management of Uncomplicated Appendicitis in Children: Results from a Multicenter Collaborative Comparative Effectiveness Study. Ann Surg. 2021. PMID: 32149827. doi:10.1097/SLA.0000000000003704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。